Seracare Life Sciences

SeraCare Life Sciences, founded in 1987 and headquartered in Milford, USA, is a key player in the clinical diagnostics quality control sector. Operating as part of LGC Clinical Diagnostics, the company provides essential tools—including reference standards, controls, and biological reagents—that enable clinical labs and IVD manufacturers to develop, validate, and monitor assays with high confidence. Its product portfolio addresses critical needs in oncology (e.g., tumor profiling, liquid biopsy), infectious disease, and reproductive health, supporting the global trend toward precision medicine and complex molecular testing. The company serves a worldwide customer base, leveraging its expertise in creating materials that mimic real patient samples to ensure test accuracy and regulatory compliance.

Design and manufacture of highly characterized biological reference materials, controls, and reagents for clinical diagnostics, specializing in multiplexed samples for NGS, molecular, and serology assays.

SeraCare competes in the clinical diagnostics QC market against major players like Thermo Fisher Scientific, Bio-Rad Laboratories, and Merck (Sigma-Aldrich), as well as specialized firms like ZeptoMetrix. Its differentiation lies in deep expertise in complex, multiplexed reference standards for NGS and a strong focus on custom solutions for assay developers.